KBRA releases its 2026 European project finance and infrastructure (PF&I) Sector Outlook, examining themes that will likely take centre stage in 2026 as well as developments and ratings trends from ...
Biogen has secured European regulatory approval for a high-dose regimen of its Spinraza drug for the neuromuscular disease spinal muscular atrophy, or SMA. Biogen on Monday said the European ...
Europe's latest measures to expand domestic critical minerals supplies lack the funding tools needed to spur investment and wrestle supplies from dominant countries like China.
Approval is supported by data from the DEVOTE study which showed the benefit of the SPINRAZA 50 mg and 28 mg regimen in both ...
The FDA has issued a complete response letter for the partners’ application in EBV+PTLD, marking the agency’s second snub of ...
Last January, Meta CEO Mark Zuckerberg said he was eager to have an ally in the White House to go after foreign regulations ...
European law firm Fieldfisher has further strengthened its regulatory offering in the Brussels office with the arrival of ...
Pharmaceutical drugs developed by two local companies received approvals in the European Union last month. On Dec. 12, Culver ...
Positive Phase 3 HERIZON-GEA-01 results for Ziihera® (zanidatamab-hrii) in first-line HER2-positive (HER2+) gastroesophageal ...
T HE EUROPEAN UNION and Mercosur, a bloc of South American countries, first started negotiating their trade deal last century ...
BioPharma Consulting Group today announced the launch of a new digital transformation advisory framework designed to ...
SAN DIEGO, CA / ACCESS Newswire / January 7, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback